Vitexin attenuates epithelial ovarian cancer cell viability and motility in vitro and carcinogenesis in vivo via p38 and ERK1/2 pathways related VEGFA

Shuzhen Zhao, Xinlei Guan, Ruijie Hou, Xueying Zhang, Fang Guo, Zhifang Zhang, Caihong Hua

Open source

DOI
10.21037/atm-20-5586
Published
2020-09
Container
Annals of Translational Medicine
Publisher
AME Publishing Company
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.21037/atm-20-5586,
  title = {Vitexin attenuates epithelial ovarian cancer cell viability and motility in vitro and carcinogenesis in vivo via p38 and ERK1/2 pathways related VEGFA},
  author = {Shuzhen Zhao and Xinlei Guan and Ruijie Hou and Xueying Zhang and Fang Guo and Zhifang Zhang and Caihong Hua},
  year = {2020},
  journal = {Annals of Translational Medicine},
  doi = {10.21037/atm-20-5586},
  url = {https://doi.org/10.21037/atm-20-5586}
}

RIS

TY  - JOUR
TI  - Vitexin attenuates epithelial ovarian cancer cell viability and motility in vitro and carcinogenesis in vivo via p38 and ERK1/2 pathways related VEGFA
AU  - Shuzhen Zhao
AU  - Xinlei Guan
AU  - Ruijie Hou
AU  - Xueying Zhang
AU  - Fang Guo
AU  - Zhifang Zhang
AU  - Caihong Hua
PY  - 2020
JO  - Annals of Translational Medicine
DO  - 10.21037/atm-20-5586
UR  - https://doi.org/10.21037/atm-20-5586
ER  - 

APA

Zhao, S., Guan, X., Hou, R., Zhang, X., Guo, F., Zhang, Z., & Hua, C. (2020). Vitexin attenuates epithelial ovarian cancer cell viability and motility in vitro and carcinogenesis in vivo via p38 and ERK1/2 pathways related VEGFA. Annals of Translational Medicine. https://doi.org/10.21037/atm-20-5586

Source records